# Riverview Bancorp Inc: overview RVSB · Nasdaq · CIK 1041368 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/rvsb.md) · [Financials](/companies/rvsb/financials.md) · [Filings](/companies/rvsb/filings.md) · [Insiders](/companies/rvsb/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.07](/filings/0001041368-26-000007.md) | [0.06](/filings/0001041368-26-000007.md) | [0.05](/filings/0001041368-26-000007.md) | [0.06](/filings/0001104659-26-096729.md) | [0.05](/filings/0001041368-26-000007.md) | [0.07](/filings/0001041368-26-000007.md) | [(0.39)](/filings/0001041368-26-000007.md) | [0.08](/filings/0001104659-26-096729.md) | | Free cash flow | $m | [(1.4) d](/filings/0001041368-25-000004.md) | [1.9 d](/filings/0001041368-26-000003.md) | [(0.2) d](/filings/0001041368-26-000007.md) | [(0.8)](/filings/0001104659-26-096729.md) | [16.4 d](/filings/0001041368-25-000004.md) | [(0.7) d](/filings/0001041368-26-000003.md) | [(3.6) d](/filings/0001041368-26-000007.md) | [1.9](/filings/0001104659-26-096729.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.98](/filings/0000939057-24-000163.md) | [0.83](/filings/0000939057-25-000159.md) | [0.18](/filings/0001041368-26-000007.md) | [0.23](/filings/0001041368-26-000007.md) | [(0.21)](/filings/0001041368-26-000007.md) | | Free cash flow | $m | [13.2](/filings/0000939057-24-000163.md) | [8.6](/filings/0000939057-25-000159.md) | [7.1](/filings/0001041368-26-000007.md) | [5.6](/filings/0001041368-26-000007.md) | [11.3](/filings/0001041368-26-000007.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rvsb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Nierenberg Investment Management Company, LLC](/funds/1282683.md) | 2026-06-30 | $11.0m | 2,032,775 | | Unchanged | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $7.3m | 1,341,963 | | Added +5,943 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $7.0m | 1,296,799 | | Reduced −1,080,369 | | [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $5.8m | 1,062,090 | | Reduced −14,360 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.8m | 883,074 | | Reduced −7,743 | | [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $4.8m | 878,059 | | Reduced −10,594 | | [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $4.1m | 749,544 | | Reduced −5,811 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $3.0m | 555,402 | | Reduced −22,698 | | [ESSEX INVESTMENT MANAGEMENT CO LLC](/funds/201772.md) | 2026-06-30 | $2.0m | 373,534 | | Reduced −16,761 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.9m | 350,030 | | Added +30,823 | ## Recent filings [All 656 filings](/companies/rvsb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-08 | 11:03 ET | [8-K/A](/filings/0000939057-26-000233.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000939057-26-000233 | | 2026-09-04 | 17:10 ET | [8-K](/filings/0000939057-26-000227.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000939057-26-000227 | | 2026-09-02 | 13:28 ET | [8-K](/filings/0000939057-26-000222.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000939057-26-000222 | | 2026-08-27 | 11:46 ET | [8-K](/filings/0000939057-26-000211.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000939057-26-000211 | | 2026-08-14 | 11:31 ET | [10-Q](/filings/0001104659-26-096729.md) | Quarterly report, period 2026-06-30 | 0001104659-26-096729 | | 2026-08-10 | 16:25 ET | [8-K](/filings/0000939057-26-000171.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000939057-26-000171 | | 2026-07-29 | 14:08 ET | [8-K](/filings/0000939057-26-000147.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939057-26-000147 | | 2026-07-17 | 14:42 ET | [DEF 14A](/filings/0001041368-26-000012.md) | Proxy statement, period 2026-03-31 | 0001041368-26-000012 | | 2026-06-12 | 15:53 ET | [10-K](/filings/0001041368-26-000007.md) | Annual report, period 2026-03-31 | 0001041368-26-000007 | | 2026-04-30 | 14:20 ET | [8-K](/filings/0000939057-26-000096.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939057-26-000096 | ## Latest annual report [Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001041368-26-000007.md), filed Jun 12, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1041368 - Tickers: RVSB - Exchange: Nasdaq - SIC code: 6035 Savings Institution, Federally Chartered - State of incorporation: WA - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 15:10 ET. No prices; not investment advice.